Concepedia
Statistics
Publications
35
Citations
3.6K
H-Index
21
Active since
1983
Affiliations
AstraZeneca (United Kingdom)(Current)
University of Manchester
C4X Discovery (United Kingdom)
Joint Research Centre
Cyprotex (United States)
David E. Leahy is an author at AstraZeneca (United Kingdom) specializing in pharmacy, pharmacokinetics, and chemistry.
Publications per year
1983–2014
Cross-validation pitfalls when selecting and assessing regression and classification models
Damjan Krstajić, Ljubomir Buturović, David E. Leahy et al. · Journal of Cheminformatics · 2014 · 1.1K citations · Full text
Computing, Cloud Computing, Computer Science +15
Physiologically Based Pharmacokinetic Modeling 1: Predicting the Tissue Distribution of Moderate-to-Strong Bases
Trudy Rodgers, David E. Leahy, Malcolm Rowland · Journal of Pharmaceutical Sciences · 2005 · 774 citations
Pharmacy, Pharmacokinetics, Physiology +13
GPTIPS: An Open Source Genetic Programming Toolbox For Multigene Symbolic Regression
Dominic P. Searson, David E. Leahy, Mark J. Willis · 2010 · 334 citations
Pharmacy, Toxicology, Computational Biology +14
Metabolism: A Bottleneck in <i>In Vitro</i> Toxicological Test Development
Sandra Coecke, H J Ahr, Bas J. Blaauboer et al. · Alternatives to Laboratory Animals · 2006 · 177 citations
Pharmacy, Pharmacokinetics, Toxicology +6
Intrinsic Molecular Volume as a Measure of the Cavity Term in Linear Solvation Energy Relationships: Octanol-Water Partition Coefficients and Aqueous Solubilities
David E. Leahy · Journal of Pharmaceutical Sciences · 1986 · 149 citations
Natural Sciences, Biophysics, Chemistry +12
1–5 of 35